DE69433745D1 - Modifizierte, verkürzte regulatoren des komplementsystems - Google Patents

Modifizierte, verkürzte regulatoren des komplementsystems

Info

Publication number
DE69433745D1
DE69433745D1 DE69433745T DE69433745T DE69433745D1 DE 69433745 D1 DE69433745 D1 DE 69433745D1 DE 69433745 T DE69433745 T DE 69433745T DE 69433745 T DE69433745 T DE 69433745T DE 69433745 D1 DE69433745 D1 DE 69433745D1
Authority
DE
Germany
Prior art keywords
regulators
proteins
shortened
modified
complement system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69433745T
Other languages
English (en)
Other versions
DE69433745T2 (de
Inventor
John P Atkinson
Dennis Hourcade
Malgorzata Krych
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Louis University
Washington University in St Louis WUSTL
Original Assignee
St Louis University
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/126,505 external-priority patent/US6897290B1/en
Application filed by St Louis University, Washington University in St Louis WUSTL filed Critical St Louis University
Application granted granted Critical
Publication of DE69433745D1 publication Critical patent/DE69433745D1/de
Publication of DE69433745T2 publication Critical patent/DE69433745T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Amplifiers (AREA)
  • Inorganic Insulating Materials (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Train Traffic Observation, Control, And Security (AREA)
DE69433745T 1993-09-24 1994-09-23 Modifizierte, verkürzte regulatoren des komplementsystems Expired - Fee Related DE69433745T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/126,505 US6897290B1 (en) 1991-05-03 1993-09-24 Modified RCA proteins
US126505 1993-09-24
PCT/US1994/010820 WO1995008343A1 (en) 1993-09-24 1994-09-23 Modified truncated complement system regulators

Publications (2)

Publication Number Publication Date
DE69433745D1 true DE69433745D1 (de) 2004-06-03
DE69433745T2 DE69433745T2 (de) 2005-05-19

Family

ID=22425192

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69433745T Expired - Fee Related DE69433745T2 (de) 1993-09-24 1994-09-23 Modifizierte, verkürzte regulatoren des komplementsystems

Country Status (7)

Country Link
EP (1) EP0730469B1 (de)
JP (1) JPH09506764A (de)
AT (1) ATE265221T1 (de)
AU (1) AU691525B2 (de)
CA (1) CA2171953C (de)
DE (1) DE69433745T2 (de)
WO (1) WO1995008343A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69735424T2 (de) * 1996-08-09 2006-10-12 Stichting Sanquin Bloedvoorziening Verfahren und mittel zur modifikation der komplementaktivierungskaskade
GB9704519D0 (en) 1997-03-05 1997-04-23 Smithkline Beecham Plc Compounds
GB9706950D0 (en) * 1997-04-05 1997-05-21 Chernajovsky Yuti Immune modulation by polypeptides related to CR1
WO2000061752A2 (en) * 1999-04-09 2000-10-19 Washington University Modified complement system regulators
BR112014013205A2 (pt) * 2011-12-01 2020-10-27 Protevobio, Inc. proteína de fusão, seu uso e seu método de produção, composição farmacêutica, ácido nucleico, e kit
US9944685B2 (en) 2012-07-02 2018-04-17 Medizinische Universität Wien Complement split product C4d for the treatment of inflammatory conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212071A (en) * 1988-04-01 1993-05-18 The Johns Hopkins University Nucleic acids encoding a human C3b/C4b receptor (CR1)
JPH0742235B2 (ja) * 1985-11-08 1995-05-10 三共株式会社 自己免疫性疾病の予防・治療剤
EP1413587A2 (de) * 1991-05-03 2004-04-28 Washington University Modifizierter Regulator des Komplementsystems

Also Published As

Publication number Publication date
ATE265221T1 (de) 2004-05-15
WO1995008343A1 (en) 1995-03-30
CA2171953A1 (en) 1995-03-30
CA2171953C (en) 2003-02-04
DE69433745T2 (de) 2005-05-19
JPH09506764A (ja) 1997-07-08
EP0730469A1 (de) 1996-09-11
EP0730469B1 (de) 2004-04-28
EP0730469A4 (de) 1999-03-31
AU691525B2 (en) 1998-05-21
AU7842494A (en) 1995-04-10

Similar Documents

Publication Publication Date Title
CA2067653A1 (en) Modified Complement System Regulator
DK0797666T3 (da) Genetisk manipulerede humane Kunitz-domæner, der inhiberer human neutrofil elastase
DE69331758D1 (de) Fibrinogen-bildungsprotein
ATE380875T1 (de) Chimäre proteine zur vermeidung der komplementaktivierung
DE68927379D1 (de) Plättchen blockierende peptide
DE69330784T2 (de) Grosse, latente komplexe von tgf-beta2 und tgf-beta3
ES2107033T3 (es) Peptidos bpc, su preparacion y su utilizacion.
DE69334146D1 (de) Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung
DE69433400D1 (de) Neue proteine von parasitischen würmern
ATE265221T1 (de) Modifizierte, verkürzte regulatoren des komplementsystems
DE68917837D1 (de) Peptid-Verbindungen.
DK403384D0 (da) Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf
ATE196926T1 (de) Gen grb3-3, variante und ihre verwendungen
DE69432427D1 (de) Tomate xyloglukan endotransglykosylase
DE69122103D1 (de) Antigerinnungspeptide
DK210088A (da) Fremgangsmaade til selektiv spaltning af peptidbindinger, isaer med henblik paa bestemmelse af aminosyresekvenser
DE69032574T2 (de) Antibakterielle- und antimalariapeptide
ATE276272T1 (de) Entzündungshemmende peptide
ES511760A0 (es) Procedimiento para eliminar el grupo n-formilo de peptidos n-formilo de peptidos n-formilados o de esteres de peptidos n-formilados.
FR2654430B1 (fr) Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.
TH19550A (th) เพปไทด์สำหรับยับยั้งการปลดปล่อยเพปซิน
TH5473A (th) สารสำหรับควบคุมความอยากอาหารหรือสารช่วยให้นอนหลับ
ATE86628T1 (de) Peptide boronsaeure-hemmungsstoffe von trypsintyp- proteasen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee